Related Experiment Video
Updated: Mar 8, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Electronic Nicotine Delivery Systems and Smoking Cessation in Arkansas, 2014
Uwemedimbuk S Ekanem1,2, Victor M Cardenas2, Ruiqi Cen2
11 Department of Community Health, Faculty of Clinical Sciences, University of Uyo, Uyo, Nigeria.
Electronic nicotine delivery systems (ENDS) use was associated with lower odds of quitting smoking among Arkansas adults. Most smokers using ENDS continued to smoke, indicating ENDS may not aid smoking cessation.
Area of Science:
- Public Health
- Tobacco Control
- Behavioral Science
Background:
- Limited evidence existed regarding electronic nicotine delivery systems (ENDS) for smoking cessation as of October 2015.
- The study investigated ENDS prevalence, impact on smoking cessation, and user beliefs in Arkansas.
Purpose of the Study:
- To determine if ENDS use was associated with lower odds of quitting smoking.
- To assess beliefs about the health risks of ENDS and their impact on tobacco-related health.
- To examine the relationship between ENDS use and smoking cessation in Arkansas.
Main Methods:
- Cross-sectional study using the 2014 Arkansas Behavioral Risk Factor Surveillance System (BRFSS) with 4465 respondents.
- Weighted analyses were employed to account for complex survey design.
- A subset of former smokers (quit within 5 years) and current smokers was analyzed to assess quitting odds.
Main Results:
- In 2014, 6.1% of Arkansas adults used ENDS; 54.1% of current or recent smokers had used ENDS.
- ENDS use was significantly associated with reduced odds of quitting smoking (OR=0.53).
- A majority of ENDS users did not believe switching to ENDS reduced health risks or that ENDS were harmless.
Conclusions:
- Most smokers who tried ENDS did not quit smoking, indicating an inverse association with smoking cessation.
- Tobacco cessation programs should inform cigarette smokers that ENDS may not be effective for quitting.
- ENDS use was inversely associated with smoking cessation outcomes in the study population.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Oral Drug Delivery Systems: Continuous-Release Systems
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...